Article 1 establishes the scope: the Regulation applies to all clinical trials conducted in the Union. It does not apply to non-interventional studies. Clinical trials defined in Article 2 are within scope; the boundary with low-intervention clinical trials is a key application question.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.